Graduate School of Medical Sciences

A protein called PAR1 helps lymphatic vessels structurally transform to boost fluid drainage and support healing when the lungs are injured according to researchers from Weill Cornell Medicine.

While glucose, or sugar, is a well-known fuel for the brain, Weill Cornell Medicine researchers have demonstrated that electrical activity in synapses—the junctions between neurons where communication occurs—can lead to the use of lipid or fat droplets as an energy source.

A pretreatment step could help transplanted pancreatic islets survive longer in patients with type 1 diabetes, according to a new preclinical study from Weill Cornell Medicine investigators. 

A rare gene mutation that delays Alzheimer’s disease does so by damping inflammatory signaling in brain-resident immune cells, according to a preclinical study led by investigators at Weill Cornell Medicine. 

 A study led by Weill Cornell Medicine investigators has found that immune tolerance to gut microbes depends on an ancient bacterial-sensing protein called STING—normally considered a trigger for inflammation. 

The award recognizes exceptional junior investigators for their notable research achievements, impactful findings and high potential for success as independent investigators.

At the 12th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium, scientists and clinicians shared their latest research which is advancing how Alzheimer’s disease is diagnosed and treated. 

A new study from researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the effectiveness of treatment.

Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center are expanding the understanding of how the BCG treatment for early bladder cancer works.

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, for years sometimes.

On May 15, Weill Cornell Medicine honored Class of 2025 graduates from Weill Cornell Medical College and the Weill Cornell Graduate School.

Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care May 14-15 during Weill Cornell Medicine’s commencement activities.

Weill Cornell Graduate School of Medical Sciences celebrated students in the Class of 2025 for their academic achievements during its convocation ceremony on May 14.

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.

More than 170 Weill Cornell Medicine leaders, donors, students and alumni gathered May 1 to celebrate the completion of the institution’s new $260 million student residence—and the reveal of its official name.

The Griffis Faculty Club buzzed with excitement as doctoral students from the Weill Cornell Graduate School of Medical Sciences presented their research, drawing peers, faculty and alumni to the 44th annual Vincent du Vigneaud Symposium on April 24.

A major new effort at Weill Cornell Medicine seeks to catalog the normal human virome, the immense ecosystem of viruses that lives in and on us.

A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy. Using yeast, the researchers reveal protein interactions that could explain how the enzyme telomerase is tightly regulated to prevent cells from dividing uncontrollably or aging prematurely.

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers.

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators.